Skip to main content
. 2018 Nov 21;16(11):458. doi: 10.3390/md16110458

Figure 3.

Figure 3

Influence of compounds 3, 4 and 11 in 6-OHDA-treated Neuro2a cells: (a) on cell viability; (b) on ROS formation. * Statistically significant differences (p ≤ 0.05) between results for 6-OHDA-treated cells and cells incubated with compounds.